Table 1: Analyzed parameters in all obese patients included in the study.

ParametersNAFLD
median; Q1–Q3
()
Non-NAFLD
median; Q1–Q3
()

Gender, M/F33/651/18NS
IL-18 (pg/ml)335; 257–493299; 219–3830.034
BMI (kg/m2)29; 27–3427; 25–310.007
Waist (cm)100; 94–10893; 86–1030.008
ALT (IU/l)64; 50–10126; 19–330.000
AST (IU/l)39; 32–5225; 21–300.000
GGT (IU/l)30; 23–4518; 14–230.000
Bilirubin (mg/dl)0.6; 0.5–0.90.6; 0.45–0.7NS
Total cholesterol (mg/dl)177; 153–216174; 145–190NS
HDL-C (mg/dl)44; 39–5146; 38–54NS
LDL-C (mg/dl)97; 79–14399; 78–116NS
TG (mg/dl)132; 85–173108; 85–142NS
Glucose (mg/dl)93; 85–9991; 86–96NS
Insulin (μIU/ml)18; 14–2215; 11–180.011
HOMA-IR4.2; 3.2–5.83.2; 2.1–40.005
Uric acid (mg/dl)6.5; 5.5–7.45.7; 4.8–6.60.023
hsCRP (mg/l)0.9; 0.7–1.81.3; 0.6–2NS
Ferritin (ng/ml)61; 50–10552; 34–650.005
A1AT (g/l)1.3; 1.2–1.51.4; 1.2–1.5NS
USG grade of steatosis2; 1–31; 0-10.000
1HMRS (r.u.)163; 106–21080; 40–1480.000